Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a Specialistwww.weightcrunchshop.com was found selling unapproved and misbranded semaglutide and opioid drugs to U.S. consumers over the internet in violation of the Federal Food, Drug, and Cosmetic Act (sections 301(a), 301(d), 301(k), 503(b), and 505(a)). The company's products circumvented FDA regulatory safeguards and posed inherent risks to consumers, as unapproved drugs may be contaminated, counterfeit, contain inconsistent active ingredient amounts, or include entirely different ingredients. The FDA requested that the company immediately cease offering these unapproved and misbranded drugs for sale to protect public health and safety.